Viewing Study NCT06994650


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-28 @ 7:00 PM
Study NCT ID: NCT06994650
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-29
First Post: 2025-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module